These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7919305)

  • 1. Surveillance of resistance to antituberculosis drugs in developing countries.
    Nunn P; Felten M
    Tuber Lung Dis; 1994 Jun; 75(3):163-7. PubMed ID: 7919305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
    Pablos-Méndez A; Raviglione MC; Laszlo A; Binkin N; Rieder HL; Bustreo F; Cohn DL; Lambregts-van Weezenbeek CS; Kim SJ; Chaulet P; Nunn P
    N Engl J Med; 1998 Jun; 338(23):1641-9. PubMed ID: 9614254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resistance and multiresistance to antitubercular drugs in Argentina and in other Latin American countries].
    de Kantor IN; Latini O; Barrera L
    Medicina (B Aires); 1998; 58(2):202-8. PubMed ID: 9706257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant tuberculosis: etiology, management and prevention.
    O'Brien RJ
    Semin Respir Infect; 1994 Jun; 9(2):104-12. PubMed ID: 7973169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995.
    Bercion R; Kuaban C
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):110-4. PubMed ID: 9441073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs].
    Garzón MC; Angée DY; Llerena C; Orjuela DL; Victoria JE
    Biomedica; 2008 Sep; 28(3):319-26. PubMed ID: 19034356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients.
    Hongthiamthong P; Chuchottaworn C; Amatayakul N
    J Med Assoc Thai; 1994 Jul; 77(7):363-7. PubMed ID: 7876754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations.
    Vareldzis BP; Grosset J; de Kantor I; Crofton J; Laszlo A; Felten M; Raviglione MC; Kochi A
    Tuber Lung Dis; 1994 Feb; 75(1):1-7. PubMed ID: 8161760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A; Mondal R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Global situation of TB and its control].
    Shimao T
    Kekkaku; 1999 Feb; 74(2):83-90. PubMed ID: 10191600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998].
    Montoro E; Echemendía M; Lemus D; Marrero A; Llanes MJ; Valdivia JA
    Biomedica; 2004 Jun; 24 Supp 1():80-4. PubMed ID: 15495575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
    Pulido F; Iribarren JA; Kindelan JM; Moreno S
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance in Mycobacterium tuberculosis.
    Cole ST; Telenti A
    Eur Respir J Suppl; 1995 Sep; 20():701s-713s. PubMed ID: 8590570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of multidrug-resistant tuberculosis.
    Iseman MD
    N Engl J Med; 1993 Sep; 329(11):784-91. PubMed ID: 8350889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current problems in treating tuberculosis in Italian HIV-infected patients.
    Monno L; Angarano G; Carbonara S; Infante G; Coppola S; Costa D; Quarto M; Pastore G
    Tuber Lung Dis; 1993 Aug; 74(4):280-7. PubMed ID: 8219181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis in Europe and Poland--new molecular families and new resistance patterns].
    Augustynowicz-Kopeć E; Zwolska Z
    Przegl Epidemiol; 2008; 62(1):113-21. PubMed ID: 18536233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia.
    Demissie M; Gebeyehu M; Berhane Y
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):64-7. PubMed ID: 9441061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.